The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Taraban, V. Y.
Right arrow Articles by Al-Shamkhani, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Taraban, V. Y.
Right arrow Articles by Al-Shamkhani, A.
The Journal of Immunology, 2004, 173: 6542-6546.
Copyright © 2004 by The American Association of Immunologists


CUTTING EDGE

Cutting Edge: A Critical Role for CD70 in CD8 T Cell Priming by CD40-Licensed APCs1

Vadim Y. Taraban, Tania F. Rowley and Aymen Al-Shamkhani2

Cancer Sciences Division, Tenovus Research Laboratory, University of Southampton School of Medicine, Southampton General Hospital, Southampton, United Kingdom

The CD154/CD40 interaction is an important pathway of CD4 T cell help for CD8 T cell responses. In this study, we address the role of CD70, a member of the TNF superfamily and the ligand for the T cell costimulatory receptor CD27, in CD40-mediated priming of CD8 T cells. Using an agonistic anti-CD40 mAb to mimic the CD154/CD40 interaction we demonstrate that the priming of OT-I TCR transgenic or endogenous mouse OVA-specific CD8 T cells is critically dependent on CD70/CD27 interaction. CD70 blockade inhibited CD40-mediated clonal expansion of CD8 T cells and reduced the number of memory CD8 T cells generated. Furthermore, CD70 blockade during the initial priming of CD8 T cells inhibited the ability of memory CD8 T cells to expand in response to a second encounter with Ag. Our data indicate that CD70 expression on APCs plays a key role in CD40-dependent CD8 T cell responses.




This article has been cited by other articles:


Home page
Int ImmunolHome page
M. Hashimoto-Okada, T. Kitawaki, N. Kadowaki, S. Iwata, C. Morimoto, T. Hori, and T. Uchiyama
The CD70-CD27 interaction during the stimulation with dendritic cells promotes naive CD4+ T cells to develop into T cells producing a broad array of immunostimulatory cytokines in humans
Int. Immunol., June 25, 2009; (2009) dxp056v1.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. M. Keller, Y. Xiao, V. Peperzak, S. H. Naik, and J. Borst
Costimulatory ligand CD70 allows induction of CD8+ T-cell immunity by immature dendritic cells in a vaccination setting
Blood, May 21, 2009; 113(21): 5167 - 5175.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
P. Krause, M. Bruckner, C. Uermosi, E. Singer, M. Groettrup, and D. F. Legler
Prostaglandin E2 enhances T-cell proliferation by inducing the costimulatory molecules OX40L, CD70, and 4-1BBL on dendritic cells
Blood, March 12, 2009; 113(11): 2451 - 2460.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. Glouchkova, B. Ackermann, A. Zibert, R. Meisel, M. Siepermann, G. E. Janka-Schaub, U. Goebel, A. Troeger, and D. Dilloo
The CD70/CD27 Pathway Is Critical for Stimulation of an Effective Cytotoxic T Cell Response against B Cell Precursor Acute Lymphoblastic Leukemia
J. Immunol., January 1, 2009; 182(1): 718 - 725.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Kim, K. Park, H. J. Kim, J. Kim, H.-A Kim, D. Jung, H. J. Kim, H.-J. Choi, S.-Y. Choi, K. W. Seo, et al.
Breaking of CD8+ T Cell Tolerance through In Vivo Ligation of CD40 Results in Inhibition of Chronic Graft-versus-Host Disease and Complete Donor Cell Engraftment
J. Immunol., November 15, 2008; 181(10): 7380 - 7389.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y. Xiao, V. Peperzak, A. M. Keller, and J. Borst
CD27 Instructs CD4+ T Cells to Provide Help for the Memory CD8+ T Cell Response after Protein Immunization
J. Immunol., July 15, 2008; 181(2): 1071 - 1082.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
C. Homig-Holzel, C. Hojer, J. Rastelli, S. Casola, L. J. Strobl, W. Muller, L. Quintanilla-Martinez, A. Gewies, J. Ruland, K. Rajewsky, et al.
Constitutive CD40 signaling in B cells selectively activates the noncanonical NF-{kappa}B pathway and promotes lymphomagenesis
J. Exp. Med., June 9, 2008; 205(6): 1317 - 1329.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
V. Y. Taraban, S. Martin, K. E. Attfield, M. J. Glennie, T. Elliott, D. Elewaut, S. Van Calenbergh, B. Linclau, and A. Al-Shamkhani
Invariant NKT Cells Promote CD8+ Cytotoxic T Cell Responses by Inducing CD70 Expression on Dendritic Cells
J. Immunol., April 1, 2008; 180(7): 4615 - 4620.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
I. M. Olazabal, N. B. Martin-Cofreces, M. Mittelbrunn, G. Martinez del Hoyo, B. Alarcon, and F. Sanchez-Madrid
Activation Outcomes Induced in Naive CD8 T-Cells by Macrophages Primed via "Phagocytic" and Nonphagocytic Pathways
Mol. Biol. Cell, February 1, 2008; 19(2): 701 - 710.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
R. R. French, V. Y. Taraban, G. R. Crowther, T. F. Rowley, J. C. Gray, P. W. Johnson, A. L. Tutt, A. Al-Shamkhani, and M. J. Glennie
Eradication of lymphoma by CD8 T cells following anti-CD40 monoclonal antibody therapy is critically dependent on CD27 costimulation
Blood, June 1, 2007; 109(11): 4810 - 4815.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
H. Soares, H. Waechter, N. Glaichenhaus, E. Mougneau, H. Yagita, O. Mizenina, D. Dudziak, M. C. Nussenzweig, and R. M. Steinman
A subset of dendritic cells induces CD4+ T cells to produce IFN-{gamma} by an IL-12-independent but CD70-dependent mechanism in vivo
J. Exp. Med., May 14, 2007; 204(5): 1095 - 1106.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. G. H. Hernandez, L. Shen, and K. L. Rock
CD40-CD40 Ligand Interaction between Dendritic Cells and CD8+ T Cells Is Needed to Stimulate Maximal T Cell Responses in the Absence of CD4+ T Cell Help
J. Immunol., March 1, 2007; 178(5): 2844 - 2852.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. J. Sanchez, J. A. McWilliams, C. Haluszczak, H. Yagita, and R. M. Kedl
Combined TLR/CD40 Stimulation Mediates Potent Cellular Immunity by Regulating Dendritic Cell Expression of CD70 In Vivo
J. Immunol., February 1, 2007; 178(3): 1564 - 1572.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Laouar, M. Manocha, M. Wan, H. Yagita, R. A. W. van Lier, and N. Manjunath
Cutting Edge: Distinct NK Receptor Profiles Are Imprinted on CD8 T Cells in the Mucosa and Periphery during the Same Antigen Challenge: Role of Tissue-Specific Factors
J. Immunol., January 15, 2007; 178(2): 652 - 656.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
V. Y. Taraban, T. F. Rowley, D. F. Tough, and A. Al-Shamkhani
Requirement for CD70 in CD4+ Th Cell-Dependent and Innate Receptor-Mediated CD8+ T Cell Priming.
J. Immunol., September 1, 2006; 177(5): 2969 - 2975.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y. Kaufmann, N. Amariglio, E. Rosenthal, Y. J. Hirsch, A. Many, and G. Rechavi
Proliferation Response of Leukemic Cells to CD70 Ligation Oscillates with Recurrent Remission and Relapse in a Low-Grade Lymphoma
J. Immunol., November 15, 2005; 175(10): 6940 - 6947.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
S. Iwamoto, M. Ishida, K. Takahashi, K. Takeda, and A. Miyazaki
Lipopolysaccharide stimulation converts vigorously washed dendritic cells (DCs) to nonexhausted DCs expressing CD70 and evoking long-lasting type 1 T cell responses
J. Leukoc. Biol., August 1, 2005; 78(2): 383 - 392.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2004 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2004 by The American Association of Immunologists, Inc. All rights reserved.